Journal of Leukocyte Biology eBioscience full spectrum cell analysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published online as doi:10.1189/jlb.0406276 on November 15, 2006

Published online before print November 15, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0406276v1
81/2/440    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matmati, M.
Right arrow Articles by Hamann, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matmati, M.
Right arrow Articles by Hamann, J.
(Journal of Leukocyte Biology. 2007;81:440-448.)
© 2007 by Society for Leukocyte Biology

The human EGF-TM7 receptor EMR3 is a marker for mature granulocytes

Mourad Matmati*, Walter Pouwels*, Robin van Bruggen{dagger}, Machiel Jansen{dagger}, Robert M. Hoek*, Arthur J. Verhoeven{dagger} and Jörg Hamann*,1

* Department of Experimental Immunology and
{dagger} Sanquin Research and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

1 Correspondence: Department of Experimental Immunology, K0-144, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands. E-mail: j.hamann{at}amc.uva.nl

EMR3 is a member of the epidermal growth factor-seven-transmembrane (EGF-TM7) family of adhesion class TM7 receptors. This family also comprises CD97, EMR1, EMR2, and EMR4. To characterize human EMR3 at the protein level, we generated Armenian hamster mAb. Using the mAb 3D7, we here demonstrate that EMR3, like other EGF-TM7 receptors, is expressed at the cell surface as a heterodimeric molecule consisting of a long extracellular {alpha}-chain, which possesses at its N-terminus EGF-like domains and a membrane-spanning ß-chain. Flow cytometric analysis revealed that all types of myeloid cells express EMR3. In peripheral blood, the highest expression of EMR3 was found on granulocytes. More mature CD16+ monocytes express high levels of EMR3, and CD16– monocytes and myeloid dendritic cells (DC) are EMR3dim/low. Lymphocytes and plasmacytoid DC are EMR3–. It is interesting that in contrast with CD97 and EMR2, CD34+CD33–/CD38– committed hematopoietic stem cells and CD34+CD33+/CD38+ progenitors in bone marrow do not express EMR3. In vitro differentiation of HL-60 cells and CD34+ progenitor cells revealed that EMR3 is only up-regulated during late granulopoiesis. These results demonstrate that the expression of EGF-TM7 receptors on myeloid cells is differentially regulated. EMR3 is the first family member found mainly on granulocytes.

Key Words: expression profiling • granulopoiesis • monoclonal antibody




This article has been cited by other articles:


Home page
 haematolHome page
M. van Pel, H. Hagoort, J. Hamann, and W. E. Fibbe
CD97 is differentially expressed on murine hematopoietic stem-and progenitor-cells
Haematologica, August 1, 2008; 93(8): 1137 - 1144.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society for Leukocyte Biology.